Fulgent Genetics Net Change in Intangible Assets 2015-2025 | FLGT

Fulgent Genetics net change in intangible assets from 2015 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
Fulgent Genetics Annual Net Change in Intangible Assets
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $0
2020 $0
2019 $N/A
2018 $N/A
2017 $N/A
2016 $N/A
2015 $N/A
2014 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.674B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $44.502B 54.47
Doximity (DOCS) United States $12.809B 56.99
Tempus AI (TEM) United States $12.797B 0.00
Hims & Hers Health (HIMS) United States $9.972B 81.70
IRhythm Technologies (IRTC) United States $5.509B 0.00
Hinge Health (HNGE) United States $4.528B 0.00
Inspire Medical Systems (INSP) United States $2.705B 39.76
Privia Health (PRVA) United States $2.677B 198.27
Heartflow (HTFL) $2.609B 0.00
Phreesia (PHR) United States $1.937B 0.00
10x Genomics (TXG) United States $1.778B 0.00
Enovis (ENOV) United States $1.749B 9.24
Omnicell (OMCL) United States $1.529B 29.45
Schrodinger (SDGR) United States $1.454B 0.00
Azenta (AZTA) United States $1.372B 59.84
Clover Health Investments (CLOV) United States $1.348B 0.00
Claritev (CTEV) United States $1.174B 0.00
Evolent Health (EVH) United States $1.133B 0.00
Zepp Health (ZEPP) Netherlands $0.550B 0.00
Veradigm (MDRX) United States $0.534B 0.00
Standard BioTools (LAB) United States $0.493B 0.00
Talkspace (TALK) United States $0.445B 133.00
Butterfly Network (BFLY) United States $0.410B 0.00
Carlsmed (CARL) United States $0.363B 0.00
TruBridge (TBRG) United States $0.300B 52.60
Health Catalyst (HCAT) United States $0.257B 0.00
Outset Medical (OM) United States $0.247B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.224B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
KORU Medical Systems (KRMD) United States $0.196B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.164B 0.00
CareCloud (CCLD) United States $0.160B 7.27
ImmunoPrecise Antibodies (IPA) Canada $0.115B 0.00
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.082B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.072B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
HeartBeam (BEAT) United States $0.044B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Precipio (PRPO) United States $0.025B 0.00
PROFUSA (PFSA) United States $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.014B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00